Keyword: Active Pharmaceutical Ingredients (APIs)


Novasep‐PharmaZell Invests €7.3 Million in APIs

27.07.2022 -

Financed in part by the French government’s France Relance plan, Novasep‐PharmaZell is investing €7.3 million in production of active pharmaceuticals (APIs) at its...


WuXi Expands API Competence in Asia

22.07.2022 -

WuXi AppTec and its subsidiary Wuxi STA have announced several investments in manufacturing and research in Asia, with the Changzou campus in China’s Jiangsu Province a...


Expansion at SK Biotek API Plant to Cost $35 Miilion

17.06.2022 -

South Korean CDMO SK Pharmteco (SKTP) said it will spend $35 million on the initial phase of a planned expansion at the Dublin, Ireland, API site the conglomerate...

Reserach & Innovation

Nanoparticle Engineering

16.05.2022 -

The value in applying AI in Pharma is in making new and better drugs available faster than would be possible otherwise. By augmenting sparse-data AI with expert knowledge...


Centrient Boosts Statins API Capacity

25.06.2021 -

Centrient Pharmaceuticals has started its expanded production of statins at its manufacturing plant for active pharmaceutical ingredients (APIs) in Toansa, India. With...


Regis Technologies Completes Lab Expansion

18.02.2021 -

US-based CDMO Regis Technologies has completed a major expansion of its laboratory facilities for development of active pharmaceutical ingredients (APIs) at its site in...


AmbioPharm Opens Shanghai Campus, Establishes Office in Switzerland

15.01.2021 -

AmbioPharm, a CDMO specializing in peptide active pharmaceutical ingredients (APIs), has opened its new Shanghai campus, adding nearly 50,000 square meters of...

Chemistry & Life Sciences

Challenges Facing Pharmaceutical Manufacturing

23.11.2020 -

Sean Diver, president of DCAT speaks about the pharmaceutical industry’s role during the Covid-19 pandemic, trends in drug manufacturing, and key issues for the EU...